Send to

Choose Destination
Endosc Int Open. 2017 Apr;5(4):E261-E271. doi: 10.1055/s-0043-102402.

Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): A cross-sectional US experience.

Author information

Department of Internal Medicine, Staten Island University Hospital, Northwell Health, Staten Island, New York, United States.
Department of Internal Medicine, Banner Baywood Medical Center, Mesa, Arizona, USA.
Prince George's Hospital Center, Cheverly, Maryland, United States.
Anatomy Department, M. P. Shah Government Medical College, India.
Department of Cardiology, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Florida, United States.
Institute of Clinical Research India (ICRI), Bangalore, India.
Touro College of osteopathic Medicine, New York, United States.
Department of Gastroenterology, Staten Island University hospital, Northwell Health, Staten Island, United States.
St. Joseph Hospital Medical center, Phoenix, Arizona, USA/Arizona Center for Digestive health, Gastroenterology, Gilbert, Arizona, United States.


Study aims The goal of our study was to determine the current trends for inpatient utilization for endoscopic retrograde cholangiopancreatography (ERCP) and its economic impact in the United States between 2002 and 2013. Patients and methods A Nationwide Inpatient Sample from 2002 through 2013 was examined. We identified ERCPs using International Classification of Diseases (ICD-9) codes; Procedure codes 51.10, 51.11, 52.13, 51.14, 51.15, 52.14 and 52.92 for diagnostic and 51.84, 51.86, 52.97 were studied. Rate of inpatient ERCP was calculated. The trends for therapeutic ERCPs were compared to the diagnostic ones. We analyzed patient and hospital characteristics, length of hospital stay, and cost of care after adjusting for weighted samples. We used the Cochran-Armitage test for categorical variables and linear regression for continuous variables. Results A total of 411,409 ERCPs were performed from 2002 to 2013. The mean age was 59 ± 19 years; 61 % were female and 57 % were white. The total numbers of ERCPS increased by 12 % from 2002 to 2011, which was followed by a 10 % decrease in the number of ERCPs between 2011 and 2013. There was a significant increase in therapeutic ERCPs by 37 %, and a decrease in diagnostic ERCPs by 57 % from 2002 to 2013. Mean length of stay was 7 days (SE = 0.01) and the mean cost of hospitalization was $20,022 (SE = 41). Conclusions Our large cross-sectional study shows a significant shift in ERCPs towards therapeutic indications and a decline in its conventional diagnostic utility. Overall there has been a reduction in inpatient ERCPs.

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York Icon for PubMed Central
Loading ...
Support Center